Medication info
Youngil Memantine Tablet (Memantine Hydrochloride)

Youngil Memantine Tablet (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Youngil Pharmaceutical Co., Ltd.
Appearance
White rectangular film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202002647 · Approved 2020.04.14 · Insurance code 649405290

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
This drug is administered orally once daily, at the same time each day. If necessary, this drug may be administered twice daily. This drug may be taken with or without food. The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows, until the maintenance dose is reached. Week 1 (Days 1~7) Administer 5mg daily for 7 days. Week 2 (Days 8~14) Administer 10mg daily for 7 days. Week 3 (Days 15~21) Administer 15mg daily for 7 days. From Week 4 onward Administer 20mg daily. Maintenance dose: The recommended maintenance dose is 20mg daily. Based on clinical data, the recommended dose in elderly patients aged 65 years and older is 20mg daily. No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated for at least 7 days after administration, the dose may be increased to 20mg daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this drug.

Ingredients

Manufacturer
Youngil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease. It may help improve the patient's memory and cognitive function.

How to take

Adult dose

This drug is administered orally once daily, at the same time each day. If necessary, this drug may be administered twice daily. This drug may be taken with or without food. The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows, until the maintenance dose is reached. Week 1 (Days 1~7) Administer 5mg daily for 7 days. Week 2 (Days 8~14) Administer 10mg daily for 7 days. Week 3 (Days 15~21) Administer 15mg daily for 7 days. From Week 4 onward Administer 20mg daily. Maintenance dose: The recommended maintenance dose is 20mg daily. Based on clinical data, the recommended dose in elderly patients aged 65 years and older is 20mg daily. No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated for at least 7 days after administration, the dose may be increased to 20mg daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this drug.

Precautions

This medicine should not be used in patients who are allergic to its components or in patients with severe liver or kidney dysfunction. Patients with epilepsy or a history of seizures, and those predisposed to seizures should use this medication with caution. Co-administration with other medications that have similar effects may increase central nervous system side effects, so combination should be avoided. Patients with altered urinary acidity or those who have recently experienced heart disease should exercise caution when using this medication. During treatment with this medicine, side effects such as dizziness, headaches, constipation, drowsiness, and hypertension may occur. If symptoms are severe, consult a doctor. It may interact with other drugs, especially antipsychotic medications, muscle relaxants, and anticoagulants, so it is important to inform your doctor if you are taking any of these. Pregnant women or those who may become pregnant should carefully consider the risks and benefits of using this medicine, and breastfeeding mothers are advised to discontinue breastfeeding while using it. Its safety and efficacy have not been established in children or adolescents under 18 years of age, so it should not be used in this population. In case of overdose, there is no specific antidote, so immediate medical attention should be sought for appropriate treatment. This medication may affect the patient's concentration and reaction speed, so caution is required when driving or operating machinery. Finally, this medication should be kept out of reach of children and should not be transferred to other containers.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • confusion
  • hallucinations
  • psychotic reactions
Show 24 more
  • balance disorders
  • gait abnormalities
  • seizures
  • heart failure
  • venous thrombosis/thromboembolism
  • dyspnea
  • vomiting
  • pancreatitis
  • elevated liver function test results
  • hepatitis
  • fatigue
  • nonspecific fatigue
  • weakness
  • diarrhea
  • anxiety
  • aggression
  • stupor
  • unconsciousness
  • restlessness
  • psychosis
  • visual disturbances
  • convulsions
  • comatose state
  • diplopia

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a tightly closed container to prevent exposure to air or moisture and kept at room temperature between 1 and 30 degrees Celsius. This will help maintain the drug's effectiveness and ensure safe use.

Appearance and packaging

Appearance

White rectangular film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.